Figure A12.7. Evidence Networks for NMA for Stroke or Systemic Embolism and Major Bleeding, Subgroup analysis by CHADS2.

Figure A12.7Evidence Networks for NMA for Stroke or Systemic Embolism and Major Bleeding, Subgroup analysis by CHADS2

From: APPENDIX 12, EVIDENCE NETWORKS

Cover of Antithrombotic Agents for the Prevention of Stroke and Systemic Embolism in Patients With Atrial Fibrillation
Antithrombotic Agents for the Prevention of Stroke and Systemic Embolism in Patients With Atrial Fibrillation [Internet].
Copyright © CADTH February 2013.

You are permitted to make copies of this document for Non-commercial purposes provided it is not modified when reproduced and appropriate credit is given to CADTH. You may not otherwise copy, modify, translate, post on a website, store electronically, republish or redistribute any material from the website in any form or by any means without the prior written permission of CADTH.

Please contact CADTH’s Vice-President of Corporate Services at ac.htdac@secivresetaroproc with any inquiries about this notice or other legal matters relating to CADTH’s services.

PubMed Health. A service of the National Library of Medicine, National Institutes of Health.